PTEN acts as a negative regulator of the AKT and TNF/NF-kappa B signaling pathways 13, and abnormal activation of AKT and TNF/NF-kappa B signaling contributes to TKI resistance in ccRCC 30, 31. The gene discussed is PTEN; the disease is nonpapillary renal cell carcinoma.